Home > Insider Trading > Filing (0001127602-13-034914)

Filing Details

Accession Number:: 0001127602-13-034914
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-17 19:11:28
Reporting Period:: 2013-12-17

Filing Date:: 2013-12-17
Accepted Time:: 2013-12-17 19:11:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1106578	A Martine Rothblatt	C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910	Ceo	Yes	Yes	No	No

Transaction Summary

Sold:	12,251 shares	Avg. Price: $86.49	Total Value: $1,059,606.30
Number of Shares After Transactions:	696,421 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-17	1,647	$86.42	707,025	No	4	S	Indirect	By Trusts
Common Stock	Disposition	2013-12-17	200	$87.27	706,825	No	4	S	Indirect	By Trusts
Common Stock	Disposition	2013-12-17	4,215	$86.41	702,610	No	4	S	Indirect	By Trusts
Common Stock	Disposition	2013-12-17	446	$87.27	702,164	No	4	S	Indirect	By Trusts
Common Stock	Disposition	2013-12-17	4,943	$86.38	697,221	No	4	S	Indirect	By Trusts
Common Stock	Disposition	2013-12-17	800	$87.14	696,421	No	4	S	Indirect	By Trusts

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Trusts
No	4	S	Indirect	By Trusts
No	4	S	Indirect	By Trusts
No	4	S	Indirect	By Trusts
No	4	S	Indirect	By Trusts
No	4	S	Indirect	By Trusts

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	140	Direct
Common Stock	166	Indirect	By Spouse

Footnotes

Shares were sold pursuant to pre-arranged 10b5-1 trading plans entered into by trusts beneficially owned by the reporting person and the reporting person's spouse.
This transaction was executed in multiple trades at prices ranging from $85.93 to $86.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $87.09 to $87.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $86.02 to $86.995. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $87.05 to $87.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $85.93 to $86.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $86.93 to $87.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.